功能性4-D聚类刻画肿瘤异质性:FDG PET作为乳腺癌预后生物标志物的评估
研究提出一种无监督聚类算法,整合马尔可夫随机场(MRF)图像分割与时间序列分析,用于动态4-D成像中刻画肿瘤内动力学异质性;在50例局部晚期乳腺癌患者治疗前动态FDG PET数据中提取功能性肿瘤异质性(FTH)特征。将FTH特征加入已知复发预测因素及FDG PET摄取与动力学标记的基线模型后,一致性统计量(C-statistic)从0.59提升至0.74(p=0.005)。无监督层次聚类识别出两种显著(p<0.001)的肿瘤异质性表型,对应高FTH与低FTH,且两表型间FDG通量(Ki)分布显著不同(p=0.04)。
要点
- FTH特征加入基线模型后C-statistic从0.59升至0.74(p=0.005)。
- 无监督层次聚类识别出高FTH与低FTH两种显著表型(p<0.001)。
- 两表型间FDG通量(Ki)分布显著不同(p=0.04)。
核心结论
- FTH影像标记在标准PET指标之外,对预测乳腺癌无复发生存具有独立附加价值,值得进一步研究。
研究设计与样本
- 提出整合MRF图像分割与时间序列分析的无监督聚类算法,用于4-D成像刻画肿瘤内动力学异质性。
- 先用模拟动态数据评估算法性能,再应用于50例局部晚期乳腺癌患者治疗前动态FDG PET数据集并随访监测复发。
- 从每例肿瘤内功能 distinct 子区域提取FTH特征,采用交叉验证的时间至事件分析比较其与既有组织病理学和动力学预后标记的预后价值。
主要发现
- 将FTH特征加入已知复发预测因素及FDG PET摄取与动力学标记的基线模型后,C-statistic从0.59提升至0.74(p=0.005)。
- 对FTH特征进行无监督层次聚类识别出两种显著(p<0.001)的肿瘤异质性表型,对应高FTH与低FTH。
- FDG通量(Ki)分布在两种表型间显著不同(p=0.04)。
临床怎么用
- 对局部晚期乳腺癌患者治疗前动态FDG PET数据可提取FTH特征,辅助在标准PET指标之外评估复发风险。
局限性
- 样本为50例局部晚期乳腺癌患者,结论需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Probe-based dynamic (4-D) imaging modalities capture breast intratumor heterogeneity both spatially and kinetically. Characterizing heterogeneity through tumor sub-populations with distinct functional behavior may elucidate tumor biology to improve targeted therapy specificity and enable precision clinical decision making. METHODS: We propose an unsupervised clustering algorithm for 4-D imaging that integrates Markov-Random Field (MRF) image segmentation with time-series analysis to characterize kinetic intratumor heterogeneity. We applied this to dynamic FDG PET scans by identifying distinct time-activity curve (TAC) profiles with spatial proximity constraints. We first evaluated algorithm performance using simulated dynamic data. We then applied our algorithm to a dataset of 50 women with locally advanced breast cancer imaged by dynamic FDG PET prior to treatment and followed to monitor for disease recurrence. A functional tumor heterogeneity (FTH) signature was then extracted from functionally distinct sub-regions within each tumor. Cross-validated time-to-event analysis was performed to assess the prognostic value of FTH signatures compared to established histopathological and kinetic prognostic markers. RESULTS: Adding FTH signatures to a baseline model of known predictors of disease recurrence and established FDG PET uptake and kinetic markers improved the concordance statistic (C-statistic) from 0.59 to 0.74 (p = 0.005). Unsupervised hierarchical clustering of the FTH signatures identified two significant (p < 0.001) phenotypes of tumor heterogeneity corresponding to high and low FTH. Distributions of FDG flux, or Ki, were significantly different (p = 0.04) across the two phenotypes. CONCLUSIONS: Our findings suggest that imaging markers of FTH add independent value beyond standard PET imaging metrics in predicting recurrence-free survival in breast cancer and thus merit further study.
引用
- Chitalia R, Viswanath V, Pantel AR, et al. Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer. Eur J Nucl Med Mol Imaging. 2021. PMID: 33677641. doi:10.1007/s00259-021-05265-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。